This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838–851 (2008)
Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59–64 (2014)
Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G168–G175 (2012)
Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562–572 (2011)
Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G675–G685 (2012)
Chavez-Tapia, N. C., Tellez-Avila, F. I., Garcia-Leiva, J. & Valdovinos, M. A. Use and overuse of proton pump inhibitors in cirrhotic patients. Med. Sci. Monit. 14, CR468–CR472 (2008)
Bajaj, J. S. et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab. Brain Dis. 27, 205–215 (2012)
Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940–947 (2014)
Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8, e60042 (2013)
Kanno, T. et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem. Biophys. Res. Commun. 381, 666–670 (2009)
Bajaj, J. S. et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am. J. Physiol. Gastrointest. Liver Physiol. 307, G951–G957 (2014)
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011)
Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem. Biodivers. 7, 1065–1075 (2010)
Zhang, Z. et al. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am. J. Gastroenterol. 108, 1601–1611 (2013)
Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 60, 823–831 (2014)
Author information
Authors and Affiliations
Contributions
J.S.B. supervised the patient recruitment, sample collection and clinical analysis. He was also involved in the data interpretation, analysis and drafting of the manuscript. N.S.B. was involved in data analysis and interpretation. P.M.G. was responsible for data analysis, interpretation and drafting of the manuscript. All authors participated in the critical revision of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bajaj, J., Betrapally, N. & Gillevet, P. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1–E2 (2015). https://doi.org/10.1038/nature14851
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature14851
This article is cited by
-
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Nature Reviews Gastroenterology & Hepatology (2021)
-
Gastrointestinale Mikrobiota bei Leberzirrhose: pathophysiologische Veränderungen und therapeutische Interventionen
Der Gastroenterologe (2020)
-
Alcohol, liver disease and the gut microbiota
Nature Reviews Gastroenterology & Hepatology (2019)
-
Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
Scientific Reports (2019)
-
The gut microbiome and liver cancer: mechanisms and clinical translation
Nature Reviews Gastroenterology & Hepatology (2017)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.